Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06654375
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-10-14
Brief Title:
Thrombectomy Versus Best Medical Management in Large Vessel Occlusion Stroke Patients Presenting Beyond 24 Hours and With Presence of Collateral Flow on CT Angiography
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Thrombectomy Versus Best Medical Management in Large Vessel Occlusion Stroke Patients Presenting Beyond 24 Hours and With Presence of Collateral Flow on CT Angiography A Multicentre Open-label Registry-linked Randomised Controlled Trial
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to investigate if endovascular treatment EVT can effectively treat patients with large vessel occlusion LVO who present beyond the typical 24-hour window after symptom onset The main questions it aims to answer are
Can EVT improve functional independence at 90 days for patients treated after 24 hours
What is the safety profile of EVT in this delayed treatment group compared to best medical management BMM Researchers will compare EVT outcomes in patients presenting after 24 hours to those receiving BMM to see if EVT offers significant benefits
Participants will
Receive either EVT or BMM based on their eligibility
Undergo CT angiography to assess collateral circulation and to confirm the presence of LVO
Be followed for 90 days to evaluate functional outcomes and safety measures
Can EVT improve functional independence at 90 days for patients treated after 24 hours
What is the safety profile of EVT in this delayed treatment group compared to best medical management BMM Researchers will compare EVT outcomes in patients presenting after 24 hours to those receiving BMM to see if EVT offers significant benefits
Participants will
Receive either EVT or BMM based on their eligibility
Undergo CT angiography to assess collateral circulation and to confirm the presence of LVO
Be followed for 90 days to evaluate functional outcomes and safety measures
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None